Each month, safety surveillance of medicines is discussed in the EU by the EU Pharmacovigilance Working Party (PhVWP). The PhVWP belongs under the London-based European Medicines Agency (EMA) and consists of representatives from every EU Member State.
The outcomes of the meetings are gathered in a monthly report, which is published after each meeting. The outcomes make up decisions on concluded reviews.
News from the PhVWP meetings
We report regularly on the topics discussed at the PhVWP meetings. See the news flow in the right-hand box.
Danish Pharmacovigilance Update also brings news from the PhVWP meetings
You can also read an extract of the PhVWP's monthly reports in Danish Pharmacovigilance Update, which takes a Danish perspective. Danish Pharmacovigilance Update is issued about a week after the Danish version 'Nyt om Bivirkninger', which is published on the third Thursday of every month (see box to the right).
In Danish Pharmacovigilance Update, you can read the Danish Health and Medicines Authority's own articles on issues within medicines safety and follow the Danish adverse reactions reports that the Danish Health and Medicines Authority receives continuously from doctors and other healthcare professionals as well as consumers and relatives.
If you have any questions to the PhVWP monthly reports, please contact the Danish Health and Medicines Authority on +45 4488 9757 or FOS-Box@dkma.dk.
